ArticlePloS one2026

Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy.

Christoph Steup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.